ARCHIVES

Ibrutinib Increases OS, PFS Versus Ofatumumab in Phase III

This article is from The Cancer Letter archive.

Vol. 37 No. 6 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: Reauthorization Bill Could Go To House Floor Next Week; Packwood Blocks Action In Senate

July 8, 1983

Dingell To Challenge NCI, NSABP Handling Of Fraud, Delays

April 8, 1994

HCFA Renamed In HHS Effort At Medicare, Medicaid Reform.

June 22, 2001

Shubick Blasts Tobacco Industry Scientists

October 4, 1974

NCAB Approves Fallout Study On Split Vote

March 13, 1981

In Brief: DCCR Advisory Committee Meeting Rescheduled; Durant To Head Cooperative Group Chairman

June 29, 1979